tiprankstipranks
Trending News
More News >
Bafna Pharmaceuticals Limited (IN:BAFNAPH)
:BAFNAPH
India Market

Bafna Pharmaceuticals Limited (BAFNAPH) Financial Statements

Compare
0 Followers

Bafna Pharmaceuticals Limited Financial Overview

Bafna Pharmaceuticals Limited's market cap is currently ₹1.75B. The company's EPS TTM is ₹0.55; its P/E ratio is 42.26; Bafna Pharmaceuticals Limited is scheduled to report earnings on May 26, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 1.46B₹ 1.52B₹ 1.15B₹ 851.40M₹ 712.18M
Gross Profit₹ 168.77M₹ 452.15M₹ 387.56M₹ 336.00M₹ 89.83M
Operating Income₹ 62.87M₹ 237.66M₹ 117.72M₹ 66.41M₹ 61.38M
EBITDA₹ 117.73M₹ 146.34M₹ 189.88M₹ 112.34M₹ 103.94M
Net Income₹ 41.52M₹ 73.48M₹ 113.38M₹ 52.16M₹ 58.27M
Balance Sheet
Cash & Short-Term Investments₹ 34.33M₹ 13.96M₹ 78.09M₹ 194.00K₹ 18.04M
Total Assets₹ 1.53B₹ 1.48B₹ 1.30B₹ 901.45M₹ 864.66M
Total Debt₹ 281.99M₹ 243.89M₹ 229.24M₹ 110.59M₹ 157.86M
Net Debt₹ 247.66M₹ 229.93M₹ 151.14M₹ 110.40M₹ 122.52M
Total Liabilities₹ 663.58M₹ 668.43M₹ 561.29M₹ 281.81M₹ 296.95M
Stockholders' Equity₹ 848.07M₹ 808.39M₹ 734.55M₹ 619.64M₹ 567.71M
Cash Flow
Free Cash Flow₹ -23.31M₹ -63.63M₹ -32.66M₹ 21.87M₹ -197.04M
Operating Cash Flow₹ 195.29M₹ 94.85M₹ 49.52M₹ 97.28M₹ -136.09M
Investing Cash Flow₹ -213.02M₹ -150.54M₹ -74.93M₹ -65.44M₹ -53.45M
Financing Cash Flow₹ 38.09M₹ -8.45M₹ 101.77M₹ -48.15M₹ 122.80M
Currency in INR

Bafna Pharmaceuticals Limited Earnings and Revenue History

Bafna Pharmaceuticals Limited Debt to Assets

Bafna Pharmaceuticals Limited Cash Flow

Bafna Pharmaceuticals Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis